Churg‐Strauss syndrome with poor‐prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty‐eight patients

Key Points

Key points are not available for this paper at this time.

Abstract

We concluded that 12 cyclophosphamide pulses were better able to control severe CSS than a 6-pulse regimen. The optimal duration of therapy remains to be determined.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Journals

Arthritis Care & Research

Institutions

University of Cambridge

Université Paris Cité

Assistance Publique – Hôpitaux de Paris

References and Citations

Add This Paper to Your Research Feed

Any time a new paper drops it will be there.